Replies to post #32969 on Decision Diagnostics Corp (DECN)

[ksviking12]

Well said.

I agree with the $0.05 - $0.10/share. It would be hard to place a PE multiple in that for me. If you look at other growth biotech companies that have gone from negative eps to positive the PE multiple typically shows more in the range of 50+. We need to see how the market accepts GenUltimate and the other new products that will be introduced.